Table of Contents
Definition / general | Essential features | Terminology | ICD coding | Epidemiology | Sites | Pathophysiology | Etiology | Diagrams / tables | Clinical features | Diagnostic criteria | Radiology description | Radiology images | Prognostic factors | Case reports | Treatment | Gross description | Gross images | Microscopic (histologic) description | Microscopic (histologic) images | Cytology description | Cytology images | Positive stains | Negative stains | Molecular / cytogenetics description | Sample pathology report | Differential diagnosis | Board review style question #1 | Board review style answer #1 | Board review style question #2 | Board review style answer #2Cite this page: Yoshikawa A. Invasive mucinous. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lungtumorinvmucadenocarcinoma.html. Accessed December 19th, 2024.
Definition / general
- Distinct variant of lung adenocarcinoma with a goblet or columnar morphology and abundant intracytoplasmic mucin
Essential features
- Rare variant of lung adenocarcinoma with a goblet or columnar morphology and abundant intracytoplasmic mucin
- No criteria regarding percentage of cells with mucin but typically homogeneous and not admixed with nonmucinous glands
- Aggressive clinical behavior often associated with intrapulmonary metastasis and recurrence
Terminology
- Colloid adenocarcinoma is currently thought to be in a separate entity according to molecular and genetic differences (J Pathol Clin Res 2017;3:139, J Thorac Oncol 2011;6:244, Transl Lung Cancer Res 2017;6:234, Am J Surg Pathol 2014;38:1118)
ICD coding
Epidemiology
- 0.2% of primary lung cancer (J Thorac Dis 2018;10:3595)
- 3 - 10% of all lung adenocarcinoma (J Thorac Oncol 2016;11:1064, Hum Pathol 2018;71:8, Histopathology 2018;73:38, Am J Surg Pathol 2014;38:1118)
- M:F = 1:2
Sites
- Lung; lower lobe predominant (J Thorac Dis 2018;10:3595)
Pathophysiology
- Associated with Ras-Raf-MEK-ERK pathway (Hum Pathol 2018;71:8, Am J Surg Pathol 2014;38:1118)
- KRAS mutation in 57 - 73%
- ALK rearrangement in minor cases
- Rare EGFR mutation
Etiology
- Less associated with smoking than other subtypes of lung adenocarcinoma
Clinical features
- Frequent intrapulmonary metastasis and recurrence
- Rare extrapulmonary and distant metastasis (J Thorac Dis 2018;10:3595)
- 80% are N0 at the time of diagnosis (versus 55% in nonmucinous adenocarcinoma)
- 80% are M0 at the time of diagnosis (versus 55% in nonmucinous adenocarcinoma)
- Larger size and higher T category at presentation
Diagnostic criteria
- Based on histological and immunohistochemical features
- Even if pathological results correspond to primary invasive mucinous adenocarcinoma of lung, colorectal adenocarcinoma must be ruled out by endoscopy and radiology
Radiology description
- Consolidation with various appearance (Eur J Radiol 2015;84:993, Cancer Imaging 2019;19:47)
- Solid lesion similar to other lung cancers
- Mixed solid and gland glass opacity lesion similar to pneumonia
- Air bronchogram is common
- Often multifocal with multilobar involvement
- FDG-PET often demonstrates relatively low accumulation to the lesion
Prognostic factors
- Intermediate to poor prognosis compared with nonmucinous adenocarcinoma (Hum Pathol 2018;71:8, J Thorac Dis 2018;10:3595, Lung Cancer 2017;109:14, J Thorac Oncol 2016;11:1064, J Thorac Oncol 2015;10:1156)
- Approximately 70% spread through air space, which is associated with higher recurrence
Case reports
- 19 year old woman with invasive mucinous adenocarcinoma (Asian Cardiovasc Thorac Ann 2018;26:635)
- 50 year old woman with invasive mucinous adenocarcinoma treated by radioablation (J Radiol Case Rep 2013;7:15)
- 62 year old woman with invasive mucinous adenocarcinoma having targetable NRG1 fusion (J Thorac Oncol 2017;12:e200)
- 68 year old man with invasive mucinous adenocarcinoma arising in a type 1 congenital pulmonary airway malformation (Acta Chir Belg 2019;1)
- 81 year old man with invasive mucinous adenocarcinoma harboring EGFR mutation (Surg Today 2015;45:1330)
Treatment
- Same as nonmucinous adenocarcinoma
- NCCN Guidelines 3.2018
- For stages I, II, IIA: surgical resection (preferred) + adjuvant chemotherapy (platinum based) and radiation
- Inoperable or metastatic: chemotherapy variable radiation
Gross description
- Gray to yellowish appearance
- Solid lesion with a gradational and ill defined border
- Mucus production inside and around the lesion
- Reference: Leslie: Practical Pulmonary Pathology - A Diagnostic Approach, 3rd edition, 2017
Gross images
Microscopic (histologic) description
- Goblet cells or GI tract type columnar cells
- No criteria regarding percentage of cells with mucin but typically homogeneous and not admixed with nonmucinous glands
- Abundant intracytoplasmic mucin
- Basally oriented nuclei with minimal atypia
- Adjacent alveolar lumens are often filled with mucin (not specific for invasive mucinous adenocarcinoma)
- Tend to be well differentiated (J Thorac Dis 2018;10:3595)
- Often predominantly lepidic growth with slight distortion / destruction of alveolar architecture
- Admixed with minor papillary, acinar or micropapillary component
- Spread through air space is common
Microscopic (histologic) images
Cytology description
- Sheets or papillary clusters of high columnar cells (Bibbo: Comprehensive Cytopathology, 4th edition, 2014)
- Abundant intracytoplasmic mucin ("gold mucin")
- Relatively small nuclei with minimal atypia
Cytology images
Positive stains
- PAS: intracellular and extracellular mucin
- HNF4α: > 90% (but also in adenocarcinoma of other origins like stomach, intestine, pancreas, ovary, uterus, cervix) (Am J Surg Pathol 2013;37:211)
- MUC2 (but also positive in adenocarcinoma of other origins like GI tract) (Am J Surg Pathol 2004;28:442)
- CK7
Negative stains
- TTF1, Napsin A: can be very weakly or focally positive in rare cases
- CDX2: variable results from different reports; per own experience, negative or rarely faintly positive (J Thorac Oncol 2011;6:244, Am J Surg Pathol 2004;28:442, Am J Surg Pathol 2013;37:211)
- CK20: equivocal, variable results from different institutions
Molecular / cytogenetics description
- HNF4α positive mucinous adenocarcinoma is often associated with KRAS or EGFR (< 5%) mutations (Am J Surg Pathol 2013;37:211)
- Some cases with HNF4α negative mucinous adenocarcinoma is associated with ALK fusion (Am J Surg Pathol 2013;37:211)
- Other mutations in KRAS negative cases include NRG1, ERBB4 and BRAF fusions (Clin Cancer Res 2014;20:3087)
Sample pathology report
- Lung, right upper lobe, resection:
- Invasive mucinous adenocarcinoma (see synoptic report)
Differential diagnosis
- Metastatic colorectal adenocarcinoma:
- Colloid adenocarcinoma (Hum Pathol 2015;46:836):
- Marked mucin pool replacing normal parenchyma
- Neoplastic epithelium floating in the mucin
- Fragments of displaced alveolar walls
- Minimal nuclear atypia
- Fibrotic encapsulation in minor cases (formerly called cystadenocarcinoma)
Board review style question #1
Board review style answer #1
E. This is metastatic colorectal adenocarcinoma which usually expresses CDX2 and CK20.
Comment Here
Reference: Invasive mucinous adenocarcinoma
Comment Here
Reference: Invasive mucinous adenocarcinoma
Board review style question #2
Which of the following findings specifically corresponds to invasive mucinous adenocarcinoma of the lung compared with other sybtypes of lung adenocarcinoma?
- Abundant mucin in air spaces
- Abundant intracytoplasmic mucin
- TTF1 positive
- Napsin A positive
- p40 positive
Board review style answer #2